Canada markets open in 2 hours 5 minutes

Vir Biotechnology, Inc. (VIR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
8.74+0.28 (+3.31%)
At close: 04:00PM EDT
8.99 +0.25 (+2.86%)
After hours: 07:49PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.19B
Enterprise Value -209.23M
Trailing P/E 5.92
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)29.72
Price/Book (mrq)0.75
Enterprise Value/Revenue -5.30
Enterprise Value/EBITDA 0.31

Trading Information

Stock Price History

Beta (5Y Monthly) 0.41
52-Week Change 3-65.73%
S&P500 52-Week Change 323.57%
52 Week High 327.48
52 Week Low 37.61
50-Day Moving Average 39.84
200-Day Moving Average 310.31

Share Statistics

Avg Vol (3 month) 31.03M
Avg Vol (10 day) 31.01M
Shares Outstanding 5135.84M
Implied Shares Outstanding 6135.84M
Float 889.98M
% Held by Insiders 114.14%
% Held by Institutions 176.07%
Shares Short (Apr 15, 2024) 45.15M
Short Ratio (Apr 15, 2024) 45.93
Short % of Float (Apr 15, 2024) 46.20%
Short % of Shares Outstanding (Apr 15, 2024) 43.79%
Shares Short (prior month Mar 15, 2024) 45.43M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-724.57%

Management Effectiveness

Return on Assets (ttm)-17.48%
Return on Equity (ttm)-33.54%

Income Statement

Revenue (ttm)86.18M
Revenue Per Share (ttm)0.64
Quarterly Revenue Growth (yoy)-66.00%
Gross Profit (ttm)N/A
EBITDA -640.57M
Net Income Avi to Common (ttm)-615.06M
Diluted EPS (ttm)-4.59
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.52B
Total Cash Per Share (mrq)11.27
Total Debt (mrq)124.54M
Total Debt/Equity (mrq)7.83%
Current Ratio (mrq)9.06
Book Value Per Share (mrq)11.80

Cash Flow Statement

Operating Cash Flow (ttm)-778.79M
Levered Free Cash Flow (ttm)-596.45M